Metabolism of aflatoxins: key enzymes and interindividual as well as interspecies differences
- 1.9k Downloads
Aflatoxins are potent hepatocarcinogen in animal models and suspected carcinogen in humans. The most important aflatoxin in terms of toxic potency and occurrence is aflatoxin B1 (AFB1). In this review, we mainly summarized the key metabolizing enzymes of AFB1 in animals and humans. Moreover, the interindividual and the interspecies differences in AFB1 metabolism are highly concerned. In human liver, CYP3A4 plays an important role in biotransforming AFB1 to the toxic product AFB1-8,9-epoxide. In human lung, CYP2A13 has a significant activity in metabolizing AFB1 to AFB1-8,9-epoxide and AFM1-8,9-epoxide. The epoxide of AFB1-8,9-epoxide could conjugate with glutathione to reduce the toxicity by glutathione-S-transferase (GST). In poultry species, CYP2A6, CYP3A37, CYP1A5, and CYP1A1 are responsible for bioactivation of AFB1. There are interindividual variations in the rate of activation of aflatoxins in various species, and there are also differences between children and adults. The age and living regions are important factors affecting resistance of species to AFB1. The rate of AFB1-8,9-epoxide formation and its conjugation with glutathione are key parameters in interspecies and interindividual differences in sensitivity to the toxic effect of AFB1. This review provides an important information for key metabolizing enzymes and the global metabolism of aflatoxins in different species.
KeywordsAflatoxins AFB1 Metabolizing enzymes Metabolism Interindividual Interspecies differences
International Agency for Research in Cancer
Microsomal epoxide hydrolase
This work was financially supported by the Project of Excellence FIM UHK and by MH CZ – DRO (UHHK, 00179906).
Conflict of interest
The authors report no conflicts of interest.
- Chou MW, Chen W (1997) Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice. J Nutr 27(2):210–217Google Scholar
- Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, Montesano R, Wild CP (1992b) Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiol Biomark Prev 1(3):221–227Google Scholar
- Halvorson MR, Phillips TD, Safe SH, Robertson LW (1985) Metabolism of aflatoxin B1 by rat hepatic microsomes induced by polyhalogenated biphenyl congeners. Appl Environ Microb 49:882–886Google Scholar
- IARC (2012) A review of human carcinogens: chemical agents and related occupations. 100: 225–244Google Scholar
- Kuilman MEM, Maas RFM, Fink-Gremmels J (2000) Cytochrome P450-mediated metabolism and cytotoxicity of aflatoxin B1 in bovine hepatocytes. Toxicology 14:321–327Google Scholar
- Wolff T, Distlerath LM, Worthington MT, Groopman JD, Hammons GJ, Kadlubar FF, Prough RA, Martin MV, Guengerich FP (1985) Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res 45:2116–2122PubMedGoogle Scholar